- Director of Research, Emergency Medicine, UH Cleveland Medical Center
Kiran Faryar, MD, MPH, is a practicing board-certified emergency physician and clinician researcher with a focus on integrating public health and public health services into emergency department settings. In 2021, she was appointed Research Director for the Department of Emergency Medicine at University Hospitals Cleveland Medical Center, where she oversees departmental research infrastructure, capacity building, and faculty research development.
Her primary research work is in the field of implementation science, investigating screening and intervention best practices in the ED. She has initiated, managed, and disseminated community health projects in both academic and community EDs including HIV, HCV, and latent TB infection screening and linkage to care; take-home naloxone distribution; initiation of medication for opioid use disorder (MOUD) for ED patients with opioid use disorder with next-day linkage to care; county-wide COVID-19 testing through an $18 million COVID program funded by the CARES Act. To date, she has over 15 peer-reviewed publications in top-tier emergency medicine and public health journals and has been awarded numerous industry, local, state, and federal grants for public health and health services.
On a national level, she is the Chair of the Society of Academic Emergency Medicine (SAEM) Research Director’s Interest Group and an active member of the SAEM EMTIDE (Emergency Medicine Transmissible Infectious Diseases and Epidemics) Interest Group.
Certifications & Memberships
- Emergency Medicine - American Board of Emergency Medicine
Fellowship | General Injury Prevention
General Injury Prevention - Medical College Of Wisconsin (2016 - 2017)
Residency | Emergency Medicine
Emergency Medicine - University Of Louisville Hospital (2013 - 2016)
Wright State University Boonshoft School Of Medicine (2008 - 2013)
Miami University (2008)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Kiran Faryar did not disclose any Outside Relationships with Industry.